Real-World Experience of MitraClip for Treatment of Severe Mitral Regurgitation - Compromise Between Mitral Regurgitation Reduction and Maintenance of Adequate Opening Area -

Circulation Journal

Volumn 76, Issue 10, 2012, Pages 2488-2493

  Chan, Pak Hei ^a,b   She, Hoi Lam ^b   Alegria Barrero, Eduardo ^a   Moat, Neil ^a   di Mario, Carlo ^a   Franzen, Olaf ^a,c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c Rigshospitalet   (Denmark)

Author keywords

Degenerative mitral regurgitation; Functional mitral regurgitation; Mitraclip; Mitral regurgitation; Mitral valve area

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; WARFARIN;

AGED; ARTICLE; BLOOD CLOTTING TIME; BLOOD VESSEL CLIP; CLINICAL ARTICLE; DEATH; DEVICE SAFETY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTATION; MALE; MITRAL VALVE REGURGITATION; MORTALITY; QUALITY OF LIFE; RISK ASSESSMENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 84867860333     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0379     Document Type: Article

References (18)

1. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, et al; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364: 1395-1406.
2. Borgia F, Di Mario C, Franzen O. Adenosine-induced asystole to facilitate MitraClip placement in a patient with adverse mitral valve morphology. Heart 2011; 97: 864.
3. Franzen O, van der Heyden J, Baldus S, Schlüter M, Schillinger W, Butter C, et al. MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011; 13: 569-576.
4. Rudolph V, Knap M, Franzen O, Schlüter M, de Vries T, Conradi L, et al. Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol 2011; 58: 2190-2195.
5. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, et al. Percutaneous mitral valve repair using the edge-toedge technique: Six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005; 46: 2134-2140.
6. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
7. Foster E, Wasserman HS, Gray W, Homma S, Di Tullio MR, Rodriguez L, et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multi-center clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007; 100: 1577-1583.
8. Ware JE, Snow KK, Kosinski M. SF-36 health survey: Manual and Interpretation Guide. Boston: New England Medical Center, The Health Institute, 1993.
9. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental summary scales: A user's manual. Boston: New England Medical Center, The Health Institute, 1994.
10. Wagner AK, Gandek B, Aaronson NK, Acquadro C, Alonso J, Apolone G, et al. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: Results from the IQOLA Project: International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 925-932.
11. Maisano F. European percutaneous mitral valve therapy experience: Acute results in the first 1,000 patients. Data from the European ACCESS Registry: What patients have been treated in Europe? TCT 2010; September 21-25, 2010; Washington, DC.
12. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in highsurgical-risk patients: Emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010; 31: 1373-1381.
13. Tamburino C, Ussia GP, Maisano F, Capodanno D, La Canna G, Scandura S, et al. Percutaneous mitral valve repair with the MitraClip system: Acute results from a real world setting. Eur Heart J 2010; 31: 1382-1389.
14. Schillinger W, Athanasiou T, Weicken N, Berg L, Tichelbäcker T, Puls M, et al. Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients. Eur J Heart Fail 2011; 13: 1331-1339.
15. Ussia GP, Cammalleri V, Sarkar K, Scandura S, Immè S, Pistritto AM, et al. Quality of life following percutaneous mitral valve repair with the MitraClip system. Int J Cardiol 2012; 155: 194-200.
16. Chan PH, Di Mario C, Franzen O. Dissociation between anatomical and functional results after MitraClip® implantation. Int J Cardiol 2012; 155: 175-176.
17. Herrmann HC, Kar S, Siegel R, Fail P, Loghin C, Lim S, et al; EVEREST Investigators. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention 2009; 4: 437-442.
18. Di Mauro M, Gallina S, D'Amico MA, Izzicupo P, Lanuti P, Bascelli A, et al. Functional mitral regurgitation: From normal to pathological anatomy of mitral valve. Int J Cardiol 2011 December 20 [Epub ahead of print].